A study on Organizational Factors Defining the Performance of Japanese Dedicated Biotech Firms: Data-Driven, International Comparison on Spin-out/Spin-off Firms from a University Versus a Corporate.
A study on Organizational Factors Defining the Performance of Japanese Dedicated Biotech Firms: Data-Driven, International Comparison on Spin-out/Spin-off Firms from a University Versus a Corporate.
批准号:
25780233
负责人:
MUNISI HawaIssa
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2013
资助国家:
日本
项目状态:
已结题
起止时间:
2013-04-01 至 2015-03-31
中文摘要
2014财年,通过迭代过程,用新获得的一组数据更新了联合预算。同时,对选定的日本dBF进行了更多的访谈,以支持这一概念和假设。在两个假设的理论细化之后,申请人将使用描述性统计和观察性案例研究的结果相结合来探索资产丰富的从母公司向新发展公司转移的概念。这项研究计划使用JABIT数据库中特定变量的统计数据比较来研究和分析30个特意选择的dBF:(I)那些被认为是公司剥离的;(Ii)那些不是公司剥离出来的,但那些通过以前在该行业的工作经验而拥有大量生物技术专业知识的高层管理人员,和(Iii)不属于这两种类型的dBFS。这一练习的结果本应用于在团队讨论后编写一篇合作论文,并用于丹麦和法国dBFS的跨地区调查结果。不幸的是,在申请人的任期于2014年3月底结束后,她找不到在没有经济支持的情况下继续在日本继续该项目的方法。然而,任何使用该项目数据的未来出版物都将以Kakeni基金的支持为特色。
英文摘要
The JABIT was updated with a newly obtained set of data in FY2014 through an iterative process. Simultaneously, additional interviews with selected Japan-based DBFs are conducted to support the notion and the hypothesis. After the theoretical refinement of the two hypotheses, the applicant will use a combination of the descriptive statistics and the results of observational case studies to explore the concept of asset-enriched transfer from parent to newly developed firms.The study planned to use statistical data comparisons on specific variables from the JABIT database to study and analyze 30 purposely selected DBFs (i) Those considered as corporate spinoffs, (ii) Those which are not corporate spinoffs but have top managers with substantial biotechnology expertise through former employment experience in the industry, and (iii) DBFs which fall in neither of the two categories.Results from this exercise were meant to be used to compile a collaborative paper after team discussions and for cross-regional findings from Denmark and France DBFs’.Unfortunately, after the applicant’s tenure ended at the end of March, 2014, she couldn't find means of continuing with the project without financial support to continue staying in Japan. However, any future publications using data from the project will feature the support of the Kakenhi funding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach
探索日本干细胞和再生医学的创新:基于联盟的方法的力量
DOI:
10.2217/rme.14.18
发表时间:
2014
期刊:
Regenerative Medicine
影响因子:
2.7
作者:
[Hawa Issa Munisi, Zhongquan Xie, Shintaro Sengoku]
通讯作者:
Shintaro Sengoku
海外基金